Tacrolimus for Remission Induction and Maintenance Therapy in Patients with Ulcerative Colitis: A Retrospective Evaluation Study
Background. In this retrospective study, we compared the efficacy of tacrolimus (TAC) or prednisolone (PSL) for maintenance therapy in patients with ulcerative colitis (UC) at remission. Methods. The study patients were followed up for at least one year after induction of remission with either PSL (...
Main Authors: | Ayumi Ito, Bunei Iizuka, Teppei Omori, Shinichi Nakamura, Katsutoshi Tokushige |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/5956316 |
Similar Items
-
Development and Improvement of Simple Colonic Mucosal Ulcer during Treatment of Severe Ulcerative Colitis with Tacrolimus
by: Ayumi Ito, et al.
Published: (2017-03-01) -
Retrospective investigation of tacrolimus combined with an anti‐tumor necrosis factorα antibody as remission induction therapy for refractory ulcerative colitis: Efficacy, safety, and relapse rate
by: Ayumi Ito, et al.
Published: (2019-12-01) -
Relationship between mucosal healing by tacrolimus and relapse of refractory ulcerative colitis: a retrospective study
by: Ayumi Ito, et al.
Published: (2020-06-01) -
Clinical Characterization of Ulcerative Colitis in Patients with Primary Sclerosing Cholangitis
by: Shun Murasugi, et al.
Published: (2020-01-01) -
The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor‐α inhibitor
by: Taketo Suzuki, et al.
Published: (2019-06-01)